ABBV Jan 2025 150.000 put
| Previous Close | 0.00 |
| Open | N/A |
| Bid | 14.50 |
| Ask | 14.85 |
| Strike | 150.00 |
| Expire Date | 2025-01-17 |
| Day's Range | 16.10 - 16.10 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 508 |
- Motley Fool
2 Relatively Safe Dividend Stocks You Won't Regret Owning
While there's no ironclad method for picking perfectly safe stocks, thankfully there are a few dividend-paying companies that are a bit less risky than average -- as a result of their history of effective competition and their management's skill at executing their business models. Both of the stocks I'll review in a moment are likely to keep growing and paying their shareholders for a very long time, and that means you aren't likely to regret making a purchase. When it comes to appealing biopharma dividend stocks that investors can depend on, AbbVie (NYSE: ABBV) is near the top of the list.
- Motley Fool
This Is the Best Dividend ETF You Can Buy
The Schwab U.S. Dividend ETF (NYSEMKT: SCHD) just went through its annual reconstitution, meaning the top positions look different than they did just a few weeks prior. AbbVie (NYSE: ABBV) is now the fund's largest weighted position.
- CNW Group
CIBC introduces additional Canadian Depositary Receipts ("CDRs")
CIBC today announced the addition of six new Canadian Depositary Receipts ("CDRs"), now listed on the NEO Exchange.
